Lametti André, Brimo Fadi, Kanber Yonca, Caglar Derin, Auger Manon
Department of Pathology, McGill University, Montreal, Quebec, Canada.
Cancer Cytopathol. 2025 May;133(5):e70016. doi: 10.1002/cncy.70016.
The third edition of The Bethesda System for Reporting Thyroid Cytopathology includes category IV, follicular neoplasm (FN), which is used to classify fine-needle aspirates of thyroid nodules that may correspond to invasive follicular-derived neoplasia other than papillary thyroid carcinoma. This diagnosis is infrequently rendered, and may represent a challenge for pathologists. This review presents a practical approach to FN and its subtype oncocytic follicular neoplasm (OFN). First, minimal criteria for the diagnosis must be achieved, namely sufficient cellularity, architectural features consistent with neoplasia, and follicular cell or oncocytic cytomorphology. Second, select diagnoses that are common or important differential diagnoses for FN or OFN must be ruled out, via a combination of morphological findings and limited ancillary tests, when available. These include follicular nodular disease, parathyroid sampling, metastatic carcinoma, noninvasive follicular thyroid neoplasm with papillary-like nuclear features, medullary thyroid carcinoma, certain subtypes of papillary thyroid carcinoma, and lymphocytic thyroiditis. This approach should allow for a careful selection of cases where diagnostic thyroid lobectomy is an appropriate therapeutic modality.
《贝塞斯达甲状腺细胞病理学报告系统》第三版包括IV类,即滤泡性肿瘤(FN),用于对甲状腺结节的细针穿刺抽吸物进行分类,这些结节可能对应于除甲状腺乳头状癌以外的侵袭性滤泡来源肿瘤。这种诊断很少做出,可能对病理学家构成挑战。本综述介绍了一种针对FN及其亚型嗜酸细胞滤泡性肿瘤(OFN)的实用方法。首先,必须达到诊断的最低标准,即足够的细胞数量、与肿瘤一致的结构特征以及滤泡细胞或嗜酸细胞的细胞形态。其次,对于FN或OFN,必须通过形态学发现和有限的辅助检查(如有)相结合,排除常见或重要的鉴别诊断。这些包括滤泡性结节性疾病、甲状旁腺采样、转移性癌、具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤、甲状腺髓样癌、某些甲状腺乳头状癌亚型以及淋巴细胞性甲状腺炎。这种方法应有助于谨慎选择诊断性甲状腺叶切除术是合适治疗方式的病例。